title: [Glycopeptide-induced cutaneous adverse reaction].
authors.forename: A
authors.initials: A
authors.lastname: Nosbaum
authors.forename: A
authors.initials: A
authors.lastname: Rozières
authors.forename: B
authors.initials: B
authors.lastname: Ben Said
authors.forename: J-F
authors.initials: JF
authors.lastname: Nicolas
authors.forename: F
authors.initials: F
authors.lastname: Bérard
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D004802:Eosinophilia / Q000139:chemically induced; D005189:False Positive Reactions; D006020:Glycopeptides / Q000009:adverse effects*; D015654:Herpesvirus 6, Human / Q000187:drug effects / Q000502:physiology; D006801:Humans; D010630:Phenindione / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D012882:Skin Tests / Q000009:adverse effects / Q000379:methods; D017334:Teicoplanin / Q000009:adverse effects / Q000494:pharmacology; D014640:Vancomycin / Q000009:adverse effects / Q000494:pharmacology; D014775:Virus Activation / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D010630:Phenindione; D017334:Teicoplanin; D014640:Vancomycin; C017673:fluindione